BSX vs RYAN · P/E 20, rev $16.75B vs P/E 43, rev $2.46B
Boston Scientific Corp (BSX) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the BSX and RYAN stock pages for the full models.
Not investment advice.